Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
Journal Article (Journal Article)
There are currently few situations in which genomic testing is actionable for genitourinary tumors. Without clear indications or treatment paradigms, genomic sequencing cannot be recommended as a standard of care for genitourinary tumors.
- Abern, MR; Dudinec, JV; Inman, BA
- May 2022
Volume / Issue
- 8 / 3
Start / End Page
- 639 - 640
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)